Depres-Brummer P - Search Results

1

Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate.

Levi F, Perpoint B, Garufi C, Focan C, Chollet P, Depres-Brummer P, Zidani R, Brienza S, Itzhaki M, Iacobelli S, et al. Levi F, et al. Eur J Cancer. 1993;29A(9):1280-4. doi: 10.1016/0959-8049(93)90073-o. Eur J Cancer. 1993. PMID: 8343268 Clinical Trial.

2

Circadian rhythm-modulated (CRM) chemotherapy of metastatic breast cancer with mitoxantrone, 5-fluorouracil, and folinic acid: preliminary results of a phase I trial.

Deprés-Brummer P, Berthault-Cvitkovic F, Lĕvi F, Brienza S, Vannetzel JM, Jasmin C, Misset JL. Deprés-Brummer P, et al. J Infus Chemother. 1995;5(3 Suppl 1):144-7. J Infus Chemother. 1995. PMID: 8528975 Clinical Trial.

3

A phase I trial of 21-day continuous venous infusion of alpha-interferon at circadian rhythm modulated rate in cancer patients.

Deprés-Brummer P, Levi F, Di Palma M, Beliard A, Lebon P, Marion S, Jasmin C, Misset JL. Deprés-Brummer P, et al. J Immunother (1991). 1991 Dec;10(6):440-7. doi: 10.1097/00002371-199112000-00008. J Immunother (1991). 1991. PMID: 1768678

4

Implications of chronobiology for 5-fluorouracil (5-FU) efficacy.

Lévi F, Brienza S, Metzer G, Deprés-Brummer P, Bertheault-Cvitkovic F, Zidani R, Adam R, Misset JL. Lévi F, et al. Adv Exp Med Biol. 1993;339:169-83. doi: 10.1007/978-1-4615-2488-5_18. Adv Exp Med Biol. 1993. PMID: 8178715 Review. No abstract available.

5

Pharmacokinetically guided melatonin scheduling in rats with circadian system suppression.

Deprés-Brummer P, Metzger G, Morin D, Urien S, Touitou Y, Tillement JP, Claustrat B, Lévi F. Deprés-Brummer P, et al. Eur J Pharmacol. 1996 Sep 26;312(2):171-8. doi: 10.1016/0014-2999(96)00491-8. Eur J Pharmacol. 1996. PMID: 8894592

6

Pharmacologic restoration of suppressed temperature rhythms in rats by melatonin, melatonin receptor agonist, S20242, or 8-OH-DPAT.

Deprés-Brummer P, Metzger G, Lévi F. Deprés-Brummer P, et al. Eur J Pharmacol. 1998 Apr 17;347(1):57-66. doi: 10.1016/s0014-2999(98)00087-9. Eur J Pharmacol. 1998. PMID: 9650848

7

Light-induced suppression of the rat circadian system.

Deprés-Brummer P, Lévi F, Metzger G, Touitou Y. Deprés-Brummer P, et al. Am J Physiol. 1995 May;268(5 Pt 2):R1111-6. doi: 10.1152/ajpregu.1995.268.5.R1111. Am J Physiol. 1995. PMID: 7771569

8

The usefulness of CA15.3, mucin-like carcinoma-associated antigen and carcinoembryonic antigen in determining the clinical course in patients with metastatic breast cancer.

Deprés-Brummer P, Itzhaki M, Bakker PJ, Hoek FJ, Veenhof KH, de Wit R. Deprés-Brummer P, et al. J Cancer Res Clin Oncol. 1995;121(7):419-22. doi: 10.1007/BF01212949. J Cancer Res Clin Oncol. 1995. PMID: 7635872 Free article.

9

In vitro chronopharmacology of recombinant mouse IL-3, mouse GM-CSF, and human G-CSF on murine myeloid progenitor cells.

Perpoint B, Le Bousse-Kerdilès C, Clay D, Smadja-Joffe F, Deprés-Brummer P, Laporte-simitsidis S, Jasmin C, Lévi F. Perpoint B, et al. Among authors: depres brummer p. Exp Hematol. 1995 Apr;23(4):362-8. Exp Hematol. 1995. PMID: 7534715

10

[Analyses of rhythms of the body temperature in free running in rats].

Deprés-Brummer P, Metzger G, Lévi F. Deprés-Brummer P, et al. Pathol Biol (Paris). 1996 Mar;44(3):150-6. Pathol Biol (Paris). 1996. PMID: 8761601 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters